Latest ArticlesTo investigate the correlation of rheumatoid arthritis (RA) disease activity, secondary infection with CD64 index, interleukins, and tumor necrosis factor (TNF)-α in patients to provide reference for the clinical treatment of RA.
A total of 63 cases of patients with RA, who were treated in Changhai hospital from September 2015 to October 2017, were selected and divided into stable stage group (n=21), active stage group (n=24) and bacterial infection group (n=18) according to clinical manifestation and laboratory results. The peripheral blood CD64 index, interleukins (IL-6, IL-8, IL-10, IL-1β, IL-2 receptor) and TNF-α levels were compared among the three groups. The correlation between CD64 index, interleukins, TNF-α and the disease activity, infection index of RA patients were analyzed.
The levels of CD64 index, IL-6, IL-8, IL-10, IL-2 receptor and TNF-α in the bacterial infection group were significantly higher than those in both active stage group and stable stage group, and those indexes in the active stage group were all higher than those in stable stage group (P<0.05 or P<0.01). The levels of CRP, ESR, PCT and ferritin in bacterial infection group were significantly higher than those in active stage group and stable stage group, and the above indexes in the active stage group were all higher than those in the stable stage group (P<0.01). After correlation analysis, in the bacterial infection group, the CD64 index was positively correlated with WBC, PCT and ferritin (r=0.800, r=0.617, r=0.567, P<0.05 or P<0.01), the IL-6 was positively correlated with CRP (r=0.800, P<0.01), and the IL-1β was positively correlated with ESR (r=0.582, P<0.05). However, in active stage group, the CD64 index was positively correlated with WBC (r=0.769, P<0.01), the IL-10 was negatively correlated with CRP (r=-0.678, P<0.01), and the IL-1β was positively correlated with ferritin (r=0.566, P<0.01). The IL-2 receptor was positively correlated with ESR (r=0.511, P<0.05).
The CD64 index, interleukins and TNF-α are closely related to the disease activity and the infection of RA patients, which can be used as the identification indexes of RA disease activity and secondary infection.
To observe the effect of amikacin sulfate combined with Guizhi Fuling capsule in the treatment of the chronic pelvic inflammation complicated with pelvic effusion.
A total of 134 patients of the chronic pelvic inflammation complicated with pelvic effusion in our hospital from August 2014 to February 2017 were selected and divided into combination therapy group and single drug group, 67 cases each group. The combination therapy group was treated with amikacin sulfate combined with Guizhi Fuling capsule, and the single drug group was treated with amikacin sulfate alone. The clinical outcomes, pain score, symptom relief time, pelvic effusion diamete, days of hospitalization, WHOQOL-BREF score, inflammatory factor levels, adverse drug reactions, and recurrence rate were compared.
After 3 days and 7 days of treatment, the cure rate, effective rate and total effective rate in combination therapy group were higher than those in single drug group, the difference was statistically significant (P<0.05). In the combination therapy group, the pain score, symptom relief time, pelvic effusion diamete and days of hospitalization were less than those in single drug group significantly (P<0.05). The health status, quality of life, self-perception and daily life score of the WHOQOL-BREF score in the combination therapy group were higher than those in single drug group significantly (P<0.05). The levels of CRP and TNF-α in the combination therapy group were lower than those in single drug group, and the IL-2 was higher than that in single drug group significantly (P<0.05). The incidence of adverse drug reactions in the combination therapy group was similar to that in single drug group, and the recurrence rate was lower than that of single drug group significantly (P<0.05).
Amikacin sulfate combined with Guizhi Fuling capsule is effective in the treatment of chronic pelvic inflammatory complicated with pelvic effusion, the symptoms are relieved, the days of hospitalization is short, alleviates the inflammatory reaction, and effectively improves the quality of life, adverse drug reactions and recurrence rate are low, which is valuable recommended for clinical widely use.
Surgical treatment is the main method for gastric cancer patients. Usually, some factors such as operation stimulation and anesthesia inhibition may easily lead to the decrease or disappearance of gastrointestinal peristalsis after operation. Enhanced recovery after surgey (ERAS) has good curative effect on the gastrointestinal function recovery in gastric cancer postoperation patients, but it is prone to intolerance. The treatment with traditional Chinese medicine has obvious advantages in regulating body imbalance and promoting the recovery of gastrointestinal function after operation. This review describes the different methods of traditional Chinese medicine and western medicine for promoting gastrointestinal function recovery after gastric cancer surgery.
Acute heart failure (AHF) is an acute attack of chronic heart disease, which has high morbidity and mortality, the quality of life is seriously affected and the economic burden of patients is increased. This review summarizes the research progress of AHF therapeutic drugs and treatment drugs for HFrEF, in order to provide a new basis for clinical reference.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by symmetric poly arthritis as the main clinical manifestation. The biological agents in RA treatment have a certain effect. Recently, the clinical studies of adalimumab obtain much progresses, especially the drug withdrawal and reduction has been attended. This review describes the recent advances of adalimumab in RA treatment, and a brief overview of its safety.
Due to less side effects and higher selectivity, the photodynamic therapy (PDT) gradually becomes an important treatment of cancer. The porfimer sodium (Photofrin) is the first approved photodynamic drug in bladder cancer, lung cancer and cervical cancer so on. This article reviews the clinical progress of porfimer sodium-PDT in cancer treatment.
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the serious complications of long-term dialysis patients, which not only affects the life quality of dialysis patients, but also increases the death risk of dialysis patients. The existing research supports that the hyperphosphatemia is the initiating factor of CKD-MBD. Effective control of serum phosphorus level can improve patients' life quality and their prognosis. Sevelamer carbonate is a new type of phosphate binder, which has the exact effect and less side effects compared with the calcium-based phosphate binders. It has been proved to have other more benefits than reducing phosphorus. This paper reviews the clinical application of sevelamer carbonate in the treatment of CKD-MBD.
Silent cerebrovascular disease (SCVD) is the most common incidental found on brain scans, and is associated with the future risk of stroke and dementia. The scientific guideline of the American heart association/American stroke association (AHA/ASA) on the prevention from stroke in the patients with SCVD, offers the suggestions for the management and future research on stroke prevention in the patients with 3 cardinal SCVD manifestations, such as silent brain infarct, white matter hyperintensities of vascular origin, and cerebral microbleed. This paper is the interpretation of this statement.
Premature ovarian insufficiency (POI) is characterized with menstrual disorder, such as hyperprolanemia and hypoestrogenism in reproductive-aged women. The hormone replacement therapy is main treatment for relieving clinical symptoms caused by low estrogen level, which can improve the quality of life. Usually, the immunotherapy can restore the ovary function and fertility of the POI patients caused by some immune diseases. Chinese medicine is also proved to be a potent effective management. Recently, the new therapies, such as assisted reproductive technology, oocyte and ovarian tissue cryopreservation and transplantation, provide some options for POI patients, who want fertility. This review describes the progress of clinical treatment for POI.
The clinical manifestations of the patients with polycystic ovary syndrome (PCOS) mainly include menstrual abnormalities, hyperandrogenism, insulin resistance, and infertility. According to the symptomatic characteristics of PCOS patients, this review describes several therapeutic approaches, such as lifestyle adjustment, oral contraceptives and ovulation induction drugs, insulin sensitizer, the laparoscopic assisted ovarian drilling and assisted reproductive technology in PCOS patients.